Sle1 and Sle3 are 2 loci that confer susceptibility to lupus nephritis in t
he NZM2410 strain of mice. Our previous work has shown that B6.NZMc1 mice,
congenic for Sle1, exhibit loss of tolerance to chromatin but do not develo
p any pathogenic autoantibodies or disease. B6.NZMc7 mice, congenic for Sle
3, exhibit low-grade polyclonal B- and T-cell activation, elevated CD4/CD8
ratios, and mildly penetrant glomerulonephritis. In contrast to these monoc
ongenics, the present study reveals that B6.NZMc1 \ c7 mice, bicongenic for
Sle1 and Sle3, exhibit splenomegaly, significantly expanded populations of
activated B and CD4(+) T cells, and a robust, variegated IgG autoantibody
response targeting multiple components of chromatin (including double-stran
ded DNA), intact glomeruli, and basement membrane matrix antigens. As one m
ight predict, these mice, particularly the females, exhibit highly penetran
t glomerulonephritis.
These findings lend strong support to a two-step epistatic model for the fo
rmation of pathogenic, nephrophilic autoantibodies in lupus. Whereas loci s
uch as Sle1 may serve to breach tolerance to chromatin, full-blown pathogen
ic maturation of the autoantibody response appears to require additional in
put from other loci (such as Sle3) and gender-based factors.